WalletHub released a new analysis ranking America's most overweight cities, based on obesity rates, health consequences and ...

Abalone Bio, an antibody company measuring large-scale activity data to drive AI-powered discovery of active therapeutics, ...

Eli Lilly launches anti-obesity and diabetes drug Mounjaro in India, priced competitively at Rs 14,000-17,500, a fraction of ...

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...

Eli Lillys famous weight loss drug will now be sold in India after the drug maker received approval from CDSCO. What are its ...

Obesity prevalence increased among both adults and children across all regions of the world from 1990 to 2021, and more than ...

The Department of Social Services remains committed to exploring policy solutions that maximize health outcomes while maintaining fiscal sustainability ...

Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...

An early-life responsive parenting intervention resulted in lower body mass index from age 3 to 9 compared with a control intervention. This group difference was driven by effects on female ...

This, she concluded, "is essential to avoid intergenerational transmission of obesity and to prevent a wave of serious health conditions and dire financial ... pain-relieving effects of cannabis ...

This economic evaluation found that although tirzepatide and semaglutide offered substantial long-term health benefits, they were not cost-effective at current net prices. Efforts to reduce the net ...